This study reviewed 15,895 intravitreal injections (9453 ranibizumab, 5386 bevacizumab, 935 triamcinolone, and 121 pegaptanib) that were performed for various indications over a 5-year period. Of the ...

We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...

Please provide your email address to receive an email when new articles are posted on . An expert panel that was convened to update guidelines for giving intravitreal injections makes clear that ...

Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.

There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...

The current standards of care involve using anti-VEGF agents, which selectively target extracellular VEGF. We've been doing this for years and those drugs do a good job, but there are limitations ...

The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...

Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...

Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening diseaseNORWICH, England & ...